THERAPEUTISCHE BEHANDLUNG

European patent · EP2694056 · In force

Register entry

Publication number
EP2694056
Application number
EP12715421
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 2, 2012
Published
Feb 12, 2014
Granted
Oct 16, 2019
Protection ends at the latest
Apr 1, 2032
Next annual fee due
Apr 30, 2026
IPC classes
A61K 31/337 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
Priority
US 201161470668 P 01.04.2011
PCT application
PCT/GB2012/050736 02.04.2012
PCT publication
WO2012/131399 04.10.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  2. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  3. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  4. Oct 16, 2019

    Granted

    Published in Swissreg on 16.10.2019

Parties

Holder

AstraZeneca AB

151 85 Södertälje, SE

Inventor

DAVIES, Barry, Robert

Macclesfield, Cheshire SK10 4TG, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.